Global Registry
A4D-Ab
Glenzocimab
A4DAB131
|
Cardiovascular / hemostasis disorders
|
Phase-II/III
Target
GP6
Isotype / Subclass
G1 / None
Company
Acticor Biotech
Clinical Status
Phase-II/III
Format
Fab
Synonyms
ACT-017
ACT017
ACT17
ACT-17
pH Formulation
—
IMGT
PubChem (385157206)
PubChem (442064642)
PubChem (472422749)
PubChem (476264151)
PubChem (476270761)
PubChem (513649704)
PubChem (513904873)
Thera-SAbDab
YAbS
Avg A4D Score
-0.7061
Score Range
-0.71
Structures
1
Show Structure Profiles
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity
Associated Structural Profiles
Level 2
Export CSV
Column Filters
Min Seq. Identity (%)
0
Min Avg A4D Score
-5.0
Max Avg A4D Score
2.0
Min pH (min agg. prop.)
0.0
Max pH (max agg. prop.)
14.0
Reset Filters
Structure ID
Source PDB
Seq. Identity
Avg. A4D Score
pH (Min Agg.)
pH (Max Agg.)
Score CDR
Score non-CDR
A4DAB131_7r58_H_L
7r58
100%
-0.7061
6.5
9.0
N/A
N/A